Novel engineered TRAIL-based chimeric protein strongly inhibits tumor growth and bypasses TRAIL resistance. (Record no. 30446483)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02203 a2200649 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250518074953.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 202104s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1097-0215 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1002/ijc.32845 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Rozga, Piotr |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20210405 |
| 245 00 - TITLE STATEMENT | |
| Title | Novel engineered TRAIL-based chimeric protein strongly inhibits tumor growth and bypasses TRAIL resistance. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | International journal of cancer |
| Date of publication, distribution, etc. | 08 2020 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1117-1130 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | A549 Cells |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Animals |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Agents |
| General subdivision | metabolism |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Apoptosis |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cell Line, Tumor |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cell Proliferation |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Resistance, Neoplasm |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | HCT116 Cells |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | HT29 Cells |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Hep G2 Cells |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Mice, SCID |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Neoplasms |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Protein Engineering |
| General subdivision | methods |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Recombinant Fusion Proteins |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | TNF-Related Apoptosis-Inducing Ligand |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Tumor Burden |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Xenograft Model Antitumor Assays |
| General subdivision | methods |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kloska, Damian |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Pawlak, Sebastian |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Teska-Kaminska, Malgorzata |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Galazka, Marlena |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bukato, Katarzyna |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Pieczykolan, Anna |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Jaworski, Albert |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Molga-Kaczmarska, Anna |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kopacz, Aleksandra |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Badyra, Bogna |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kachamakova-Trojanowska, Neli |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Zolnierkiewicz, Olga |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Targosz-Korecka, Marta |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Poleszak, Katarzyna |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Szymanik, Michal |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Zerek, Bartlomiej |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Pieczykolan, Jerzy |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Jozkowicz, Alicja |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Grochot-Przeczek, Anna |
| 773 0# - HOST ITEM ENTRY | |
| Title | International journal of cancer |
| Related parts | vol. 147 |
| -- | no. 4 |
| -- | p. 1117-1130 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1002/ijc.32845">https://doi.org/10.1002/ijc.32845</a> |
| Public note | Available from publisher's website |
No items available.